Literature DB >> 16932395

Does enzyme replacement therapy improve symptoms of Fabry disease in patients undergoing dialysis?

Maryam Banikazemi1, Robert J Desnick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16932395     DOI： 10.1038/ncpneph0100

Source DB:  PubMed          Journal:  Nat Clin Pract Nephrol        ISSN： 1745-8323


× No keyword cloud information.
  2 in total

1.  The prevalence of Fabry disease in a statewide chronic kidney disease cohort - Outcomes of the aCQuiRE (Ckd.Qld fabRy Epidemiology) study.

Authors:  Andrew Mallett; Phoebe Jane Kearey; Anne Cameron; Helen G Healy; Charles Denaro; Mark Thomas; Vincent W Lee; Samantha Louise Stark; Maria Fuller; Zaimin Wang; Wendy E Hoy
Journal:  BMC Nephrol       Date:  2022-05-04       Impact factor: 2.585

2.  The Ckd. Qld fabRy Epidemiology (aCQuiRE) study protocol: identifying the prevalence of Fabry disease amongst patients with kidney disease in Queensland, Australia.

Authors:  Andrew Mallett; Phoebe Kearey; Anne Cameron; Helen Healy; Charles Denaro; Mark Thomas; Vincent W Lee; Samantha Stark; Maria Fuller; Wendy E Hoy
Journal:  BMC Nephrol       Date:  2020-02-22       Impact factor: 2.388
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.